Galena BioPharma Articles
Galena Biopharma leaps on deal with Teva for NeuVax in Israel
5 December 2012
Roche signs up to $490 million accord with PTC Thera for SMA program; and deal with Galena
30 November 2011
Showing 1-2 of 2 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
